Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Factors affecting IgA related hyperviscosity.

U Alkner, U B Hansson, F D Lindström

Clinical and Experimental Immunology

|March 1, 1983

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

alpha(1) Antitrypsin deficiency in a patient with systemic vasculitis and primary Sjögren's syndrome.

Annals of the rheumatic diseases·2002

Same author

Iron and vitamin deficiencies, endocrine and immune status in patients with primary Sjögren's syndrome.

Oral diseases·2001

Same author

Allergen-induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of interleukin-4 and sVCAM-1.

Allergy·1999

Same author

Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2-macroglobulin.

Thorax·1998

Same author

Surface properties of antigen-antibody complexes.

Scandinavian journal of immunology·1997

Same author

Conformational isomerism of IgG antibodies.

Biochimica et biophysica acta·1997

Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026

Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026

Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026

Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026

Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026

Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026

See all related articles

High IgA concentrations in patients with IgA M-component can cause hyperviscosity. This study investigated the molecular properties of IgA contributing to hyperviscosity in monoclonal gammopathy.

Area of Science:

Immunology
Biochemistry
Hematology

Background:

Immunoglobulin A (IgA) M-component is associated with various hematological conditions.
Hyperviscosity syndrome (HVS) can complicate monoclonal gammopathies, impacting patient health.
Understanding the molecular basis of IgA hyperviscosity is crucial for diagnosis and management.

Purpose of the Study:

To investigate the physicochemical properties of IgA M-components in patients with monoclonal gammopathy.
To determine the relationship between IgA concentration, molecular form (monomeric/dimeric), and hyperviscosity.
To explore the role of hydrophobic interactions and microenvironmental factors in IgA-induced hyperviscosity.

Main Methods:

Analysis of serum samples from 14 patients with IgA M-component (6 myelomatosis, 8 benign monoclonal gammopathy).

Related Experiment Videos

Measurement of serum IgA and total protein concentrations.

Assessment of hyperviscosity (HV) and hyperviscosity syndrome (HVS).

Circular dichroism and hydrophobic interaction chromatography to analyze IgA structure and properties.

Main Results:

All six patients with high IgA (>40 g/l) and total protein (>100 g/l) concentrations exhibited hyperviscosity.
Four of these patients presented with hyperviscosity syndrome.
No correlation was found between IgA dimers/polymers and the presence of HV or HVS.
Differences in the microenvironment and hydrophobicity of monomeric and dimeric IgA were observed between normal and myeloma sera.

Conclusions:

Elevated IgA and total protein levels are strongly associated with hyperviscosity in IgA M-component disorders.
The quantity of IgA dimers or polymers does not directly correlate with hyperviscosity.
Hydrophobic interactions and alterations in the IgA microenvironment may play a significant role in the development of hyperviscosity.